EFFECTS OF L-156,602, A C5A RECEPTOR ANTAGONIST, ON MOUSE EXPERIMENTAL-MODELS OF INFLAMMATION

被引:16
作者
TSUJI, RF
MAGAE, J
NAGAI, K
YAMASAKI, M
机构
[1] TOKYO INST TECHNOL, DEPT BIOENGN, MIDORI KU, YOKOHAMA, KANAGAWA 227, JAPAN
[2] UNIV TOKYO, DEPT AGR CHEM, IMMUNOPATHOL, TOKYO 113, JAPAN
关键词
D O I
10.1271/bbb.56.2034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
L-156,602, a C5a receptor antagonist, was found as an immunosuppressant with preferential effects on delayed-type hypersensitivity (DTH) in our screening program and it was shown that L-156,602 suppressed the efferent phase of DTH. Here, we tested its.effects on experimental models of inflammation induced in mice. L-156,602 did not suppress serotonin- and carrageenan- induced inflammation while it completely suppressed concanavalin A-induced inflammation 4 h after elicitation. The inflammation appeared 24 h after the elicitation with concanavalin A and it was significantly suppressed by L-156,602. Muramyl dipeptide (MDP)-induced acute joint inflammation was also significantly suppressed by L-156,602. These results demonstrated the unique immunomodulating properties of L-156,602 in mouse experimental models of inflammation.
引用
收藏
页码:2034 / 2036
页数:3
相关论文
共 19 条
[1]  
CATANZARO PJ, 1971, AM J PATHOL, V104, P387
[2]   ARTHRITIS IN RATS AFTER SYSTEMIC INJECTION OF STREPTOCOCCAL CELLS OR CELL-WALLS [J].
CROMARTIE, WJ ;
CRADDOCK, JG ;
SCHWAB, JH ;
ANDERLE, SK ;
YANG, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (06) :1585-1602
[3]   MINIMAL STRUCTURAL REQUIREMENTS FOR ADJUVANT ACTIVITY OF BACTERIAL PEPTIDOGLYCAN DERIVATIVES [J].
ELLOUZ, F ;
ADAM, A ;
CIORBARU, R ;
LEDERER, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 59 (04) :1317-1325
[4]   A NEW DEPSIPEPTIDE ANTIBIOTIC, CITROPEPTIN [J].
HAYAKAWA, Y ;
NAKAGAWA, M ;
TODA, Y ;
SETO, H .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1990, 54 (04) :1007-1011
[5]   L-156,602, A C5A ANTAGONIST WITH A NOVEL CYCLIC HEXADEPSIPEPTIDE STRUCTURE FROM STREPTOMYCES-SP MA6348 - FERMENTATION, ISOLATION AND STRUCTURE DETERMINATION [J].
HENSENS, OD ;
BORRIS, RP ;
KOUPAL, LR ;
CALDWELL, CG ;
CURRIE, SA ;
HAIDRI, AA ;
HOMNICK, CF ;
HONEYCUTT, SS ;
LINDENMAYER, SM ;
SCHWARTZ, CD ;
WEISSBERGER, BA ;
WOODRUFF, HB ;
ZINK, DL ;
ZITANO, L ;
FIELDHOUSE, JM ;
ROLLINS, T ;
SPRINGER, MS ;
SPRINGER, JP .
JOURNAL OF ANTIBIOTICS, 1991, 44 (02) :249-254
[6]   ACTIVATION OF THE HUMAN-COMPLEMENT CASCADE BY BACTERIAL-CELL WALLS, PEPTIDOGLYCANS, WATER-SOLUBLE PEPTIDOGLYCAN COMPONENTS, AND SYNTHETIC MURAMYLPEPTIDES - STUDIES ON ACTIVE COMPONENTS AND STRUCTURAL REQUIREMENTS [J].
KAWASAKI, A ;
TAKADA, H ;
KOTANI, S ;
INAI, S ;
NAGAKI, K ;
MATSUMOTO, M ;
YOKOGAWA, K ;
KAWATA, S ;
KUSUMOTO, S ;
SHIBA, T .
MICROBIOLOGY AND IMMUNOLOGY, 1987, 31 (06) :551-569
[7]   MURAMYL DIPEPTIDE INDUCES ACUTE JOINT INFLAMMATION IN THE MOUSE [J].
KOGA, T ;
KAKIMOTO, K ;
HIROFUJI, T ;
KOTANI, S ;
SUMIYOSHI, A ;
SAISHO, K .
MICROBIOLOGY AND IMMUNOLOGY, 1986, 30 (07) :717-723
[8]   POLYARTHRITIS IN RATS FOLLOWING THE SYSTEMIC INJECTION OF LACTOBACILLUS-CASEI CELL-WALLS IN AQUEOUS SUSPENSION [J].
LEHMAN, TJA ;
ALLEN, JB ;
PLOTZ, PH ;
WILDER, RL .
ARTHRITIS AND RHEUMATISM, 1983, 26 (10) :1259-1265
[9]   MECHANISMS OF PHYTOHEMAGGLUTININ-P-INDUCED, CONCANAVALIN-A-INDUCED AND KAOLIN-INDUCED EDEMAS IN RAT [J].
LEWIS, AJ ;
COTTNEY, J ;
NELSON, DJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 40 (01) :1-8
[10]   MICROBIAL PRODUCTS .8. AZINOTHRICIN, A NOVEL HEXADEPSIPEPTIDE ANTIBIOTIC [J].
MAEHR, H ;
LIU, CM ;
PALLERONI, NJ ;
SMALLHEER, J ;
TODARO, L ;
WILLIAMS, TH ;
BLOUNT, JF .
JOURNAL OF ANTIBIOTICS, 1986, 39 (01) :17-25